Search

This work describes the use of a laser-induced breakdown spectroscopy (LIBS) system to conduct macroscopic elemental mapping of uranium and iron on the exterior surface and interior center cross-section of surrogate nuclear debris for the first time. The results suggest that similar LIBS systems could be packaged for use as an effective instrument for screening samples during collection activities in the field or to conduct process control measurements during the production of debris surrogates. The technique focuses on the mitigation of chemical and physical matrix effects of four uranium atomic emission lines, relatively free of interferences and of good analytical value. At a spatial resolution of 0.5 mm, a material fractionation pattern in the surrogate debris is identified and discussed in terms of constituent melting temperatures and thermal gradients experienced.

Portable instruments based on X-Ray Fluorescence Spectrometry (XRF) have the potential to assist in field-based studies provided the data produced are reliable. In this study, we evaluate the performance of two different types of XRF instrument (XOS prototype, and Thermo Niton XL3t). These two XRF analyzers were evaluated in a laboratory setting, and data were reported for 17 elements (As, Ba, Cd, Co, Cr, Cu, Fe, Hg, Mn, Ni, Pb, Se, Sn, Sr, Ti, V, and Zn). Samples analyzed (n=38) included ethnic herbal medicine products (HMP), ethnic spices (ES), and cosmetic products (CP). Comparison analyses were carried out using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). In general, results reported for Cd, Cu and Pb by the XOS prototype analyzer, and based on the instrument's non-metal mode, were negatively biased (5 % to 95 %) compared to ICP-OES. In contrast, results reported for Pb, As, Cd, Cu and Zn by the Niton, based on using the soil mode, were positively biased, in some instances (Cd) by up to 4 orders of magnitude. While the sensitivity of both instruments was insufficient for reliably "quantifying" toxic elements below 15 mg/kg, XRF was still capable of positively "detecting" many elements at the low single digit mg/kg levels. However, for semi-quantification estimates of contaminants at higher levels, and with limited sample preparation, both XRF instruments were deemed fit for the purpose. This study demonstrates that modern XRF instrumentation is valuable for characterizing the elemental content of food, cosmetic, and medicinal products. The technology is particularly useful for rapidly screening large numbers of products (100s per day) in the field, and quickly identifying those that may contain potentially hazardous levels of toxic elements. Toxic elements can be confirmed by examining the raw spectrum, and the limitations of factory-based calibration are generally manageable for field-based studies.

Assessment of trace elements such as Cu, Zn, and Se in patients with neurodegenerative disease, such as Alzheimer's (AD) and Parkinson's disease (PD), may be useful in etiologic studies and in assessing the risk of developing these conditions. A prototype point-of-care (POC) instrument based on monochromatic x-ray fluorescence (M-XRF) was assembled and evaluated for the determination of Cu, Zn, and Se in whole blood, plasma, and urine. The prototype instrument was validated using certified reference materials for Cu and Zn in serum/plasma, and the reported bias and relative imprecision were <10%. The M-XRF prototype performance was further assessed using human specimens collected from AD and PD subjects, and was found to be satisfactory (<20% bias) for monitoring Cu and Zn levels in plasma and whole blood. However, the prototype M-XRF sensitivity was not sufficient for quantifying Cu, Zn, or Se in urine. Nonetheless, while validating the prototype instrument, body fluids (whole blood, plasma, and urine) were collected from 19 AD patients, 23 PD patients, and 24 controls specifically for trace element analysis using well-validated methods based on inductively coupled plasma mass spectrometry (ICP-MS). This limited biomonitoring study provided robust data for up to 16 elements including Sb, As, Ba, Cd, Cs, Co, Cr, Cu, Hg, Pb, Mo, Se, Tl, Sn, Zn, and U in plasma, whole blood, and urine. The results did not indicate any significant differences in most trace elements studied between AD or PD patients compared to controls, although the sample size is limited. A statistically significant increase in plasma Se was identified for PD patients relative to AD patients, but this could be due to age differences.